BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Belga S, Doucette KE. Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon. World J Gastroenterol 2016; 22(4): 1650-1663 [PMID: 26819530 DOI: 10.3748/wjg.v22.i4.1650]
URL: https://www.wjgnet.com/1007-9327/full/v22/i4/1650.htm
Number Citing Articles
1
Paul Carrier, Marie Essig, Marilyne Debette-Gratien, Denis Sautereau, Annick Rousseau, Pierre Marquet, Jérémie Jacques, Véronique Loustaud-Ratti. Anti-hepatitis C virus drugs and kidneyWorld Journal of Hepatology 2016; 8(32): 1343-1353 doi: 10.4254/wjh.v8.i32.1343
2
Experimental and Clinical Transplantation 2017; 15(1) doi: 10.6002/ect.2015.0341
3
Ramin Yaghobi, Mohammad Javad Kazemi, Bita Geramizadeh, Seyed Ali Malek Hosseini, Javad Moayedi. Significance of Occult Hepatitis C Virus Infection in Liver Transplant Patients With Cryptogenic CirrhosisExperimental and Clinical Transplantation 2020; 18(2): 206 doi: 10.6002/ect.2017.0332
4
K.E. Doucette, K. Halloran, A. Kapasi, D. Lien, J.G. Weinkauf. Outcomes of Lung Transplantation in Recipients With Hepatitis C Virus InfectionAmerican Journal of Transplantation 2016; 16(8): 2445 doi: 10.1111/ajt.13796
5
Parmvir Parmar, Curtis Cooper. Management of hepatitis C in a patient undergoing solid organ (kidney) transplantOfficial Journal of the Association of Medical Microbiology and Infectious Disease Canada 2018; 3(4): 231 doi: 10.3138/jammi.2017-0009
6
Muhammad Nauman Zahid. Transplantation of Organs from Hepatitis C Virus-Positive Donors under Direct-Acting Antiviral RegimensJournal of Clinical Medicine 2022; 11(3): 770 doi: 10.3390/jcm11030770
7
J.A. Torres-Díaz, E.A. Jasso-Baltazar, L. Toapanta-Yanchapaxi, J. Aguirre-Valadez, L. Martínez-Matínez, A. Sánchez-Cedillo, D. Aguirre-Villarreal, I. García-Juárez. Donantes de virus de la hepatitis C positivo en receptores negativo para trasplante hepático. ¿Es posible en México?Revista de Gastroenterología de México 2023; 88(4): 392 doi: 10.1016/j.rgmx.2023.08.004
8
Ayman Yosry, Hadeel Gamal Eldeen, Eman Medhat, Mai Mehrez, Naglaa Zayed, Wafaa Elakel, Reham Abdelmoniem, Mona Kaddah, Ashraf Abdelaziz, Gamal Esmat, Magdy EL‐Serafy, Wahid Doss. Efficacy and safety of sofosbuvir‐based therapy in hepatitis C virus recurrence post living donor liver transplant: A real life egyptian experienceJournal of Medical Virology 2019; 91(4): 668 doi: 10.1002/jmv.25362
9
Megan K. Morales, Matthew Cooper, Peter Abrams, Joseph G. Timpone. Principles and Practice of Transplant Infectious Diseases2019; : 73 doi: 10.1007/978-1-4939-9034-4_4
10
Nael Hawwa, David O. Taylor. Contemporary Heart TransplantationOrgan and Tissue Transplantation 2019; : 1 doi: 10.1007/978-3-319-33280-2_4-2
11
Jefferson L. Vieira, Mandeep R. Mehra. Heart transplantation candidacyCurrent Opinion in Organ Transplantation 2021; 26(1): 69 doi: 10.1097/MOT.0000000000000828
12
A.E. Shafii, D.D. Harris, M. Baz. Clearance of Hepatitis C Virus Prior to Lung Transplantation: A Case ReportTransplantation Proceedings 2017; 49(7): 1682 doi: 10.1016/j.transproceed.2017.06.002
13
Martina Vitrone, Roberto Andini, Irene Mattucci, Ciro Maiello, Luigi Atripaldi, Emanuele Durante‐Mangoni, Rosa Zampino. Direct antiviral treatment of chronic hepatitis C in heart transplant recipientsTransplant Infectious Disease 2018; 20(1) doi: 10.1111/tid.12813
14
Wolfgang Poller, Ziya Kaya, Marion Muche, Mario Kasner, Carsten Skurk, Kai Kappert, Rudolf Tauber, Felicitas Escher, Heinz-Peter Schultheiss, Hans-Jörg Epple, Ulf Landmesser. High incidence of cardiac dysfunction and response to antiviral treatment in patients with chronic hepatitis C virus infectionClinical Research in Cardiology 2017; 106(7): 551 doi: 10.1007/s00392-017-1086-1
15
Mihai Lucian Zabara, Irinel Popescu, Alexandru Burlacu, Oana Geman, Radu Adrian Crisan Dabija, Iolanda Valentina Popa, Cristian Lupascu. Machine Learning Model Validated to Predict Outcomes of Liver Transplantation Recipients with Hepatitis C: The Romanian National Transplant Agency Cohort ExperienceSensors 2023; 23(4): 2149 doi: 10.3390/s23042149
16
Núria Esforzado, José María Morales. Hepatitis C y trasplante renal: el tiempo de la erradicación del virus ha llegadoNefrología 2019; 39(5): 458 doi: 10.1016/j.nefro.2019.01.002
17
Nael Hawwa, David O. Taylor. Contemporary Heart TransplantationOrgan and Tissue Transplantation 2020; : 37 doi: 10.1007/978-3-319-58054-8_4
18
Yeahwa Hong, Caitlin D. Couper, Nidhi Iyanna, Nicholas R. Hess, Luke A. Ziegler, Mohamed Abdullah, Michael A. Mathier, Gavin W. Hickey, Mary E. Keebler, Scott C. Silvestry, David Kaczorowski. Mid-term Waitlist and Posttransplant Outcomes With Hepatitis C-positive Donor HeartsTransplantation 2024;  doi: 10.1097/TP.0000000000005193
19
J.A. Torres-Díaz, E.A. Jasso-Baltazar, L. Toapanta-Yanchapaxi, J. Aguirre-Valadez, L. Martínez-Matínez, A. Sánchez-Cedillo, D. Aguirre-Villarreal, I. García-Juárez. Hepatitis C virus-positive donors in HCV-negative recipients in liver transplantation: Is it possible in Mexico?Revista de Gastroenterología de México (English Edition) 2023; 88(4): 392 doi: 10.1016/j.rgmxen.2023.08.002
20
B. Khan, L.G. Singer, L.B. Lilly, C. Chaparro, T. Martinu, S. Juvet, M. Pipkin, T.K. Waddell, S. Keshavjee, A. Humar, M. Cypel. Successful Lung Transplantation From Hepatitis C Positive Donor to Seronegative RecipientAmerican Journal of Transplantation 2017; 17(4): 1129 doi: 10.1111/ajt.14137
21
Hanzada Mohamed El Maghrabi, Ahmed Yahia Elmowafy, Ayman Fathi Refaie, Mohammed Adel Elbasiony, Gamal Elsayed Shiha, Lionel Rostaing, Mohamed Adel Bakr. Efficacy and safety of the new antiviral agents for the treatment of hepatitis C virus infection in Egyptian renal transplant recipientsInternational Urology and Nephrology 2019; 51(12): 2295 doi: 10.1007/s11255-019-02272-5
22
Sook Jin Lee, Kyung Hee Kim, Suk Keun Hong, Shelley Hankins. Evaluation of a Heart Transplant CandidateCurrent Cardiology Reports 2017; 19(12) doi: 10.1007/s11886-017-0934-y
23
Hideki Ohdan. Should organs from hepatitis C virus-infected donors be used for transplantation in the era of DAAs?Transplant International 2017; 30(9): 860 doi: 10.1111/tri.12971
24
Wolfgang Poller, Arash Haghikia, Mario Kasner, Ziya Kaya, Udo Bavendiek, Heiner Wedemeier, Hans-Jörg Epple, Carsten Skurk, Ulf Landmesser. Cardiovascular Involvement in Chronic Hepatitis C Virus Infections – Insight from Novel Antiviral TherapiesJournal of Clinical and Translational Hepatology 2018; 6(2): 1 doi: 10.14218/JCTH.2017.00057
25
Maria Stepanova, Trevor Locklear, Nila Rafiq, Alita Mishra, Chapy Venkatesan, Zobair M. Younossi. Long‐term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registryClinical Transplantation 2016; 30(12): 1570 doi: 10.1111/ctr.12859
26
Chen-Hua Liu, Yih-Sharng Chen, Sheoi-Shen Wang, Chun-Jen Liu, Tung-Hung Su, Hung-Chih Yang, Chun-Ming Hong, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao. Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients With Chronic Hepatitis C Virus InfectionClinical Infectious Diseases 2018; 66(2): 289 doi: 10.1093/cid/cix787
27
Núria Esforzado, José María Morales. Hepatitis C and kidney transplant: The eradication time of the virus has arrivedNefrología (English Edition) 2019; 39(5): 458 doi: 10.1016/j.nefroe.2019.01.009
28
Nicole Theodoropoulos, Bryan A. Whitson, Stanley I. Martin, Stephanie Pouch, Amy Pope‐Harman. Successful treatment of donor‐derived hepatitis C infection in a lung transplant recipientTransplant Infectious Disease 2017; 19(2) doi: 10.1111/tid.12659
29
Mário J. Silva, Cláudia Pereira, Rafaela Loureiro, Catarina Balsa, Paulo Lopes, Ivone Água-Doce, Elsa Belo, Helena C. Martins, Rodrigo Coutinho, Elizabeth Pádua. Hepatitis C in a Mobile Low-Threshold Methadone ProgramEuropean Journal of Gastroenterology & Hepatology 2017; 29(6): 657 doi: 10.1097/MEG.0000000000000843
30
Denise J. Lo, Blayne A. Sayed, Nicole A. Turgeon. Pancreas transplantation in unconventional recipientsCurrent Opinion in Organ Transplantation 2016; 21(4): 393 doi: 10.1097/MOT.0000000000000334
31
Saima Aslam, Paolo Grossi, Kelly H. Schlendorf, Are M. Holm, Ann E. Woolley, Emily Blumberg, Mandeep R. Mehra, Saima Aslam, Mandeep R. Mehra, Emily Blumberg, Paolo Grossi, Are M. Holm, Kelly H. Schlendorf, Ann E. Woolley, Fernanda P. Silveira, Jeffrey Teuteberg, Maria Crespo, Haifa Lyster, Laura Lourenco, Sara Machado, Michael Shullo, Matthew Hartwig, Miranda Peraskeva, Cameron Wolfe, Kiran Khush, Michael Ison, Shelley Hall, Joshua Mooney, Steve Ivulich, Marcelo Cypel, Victor Pretorius, Patricia Uber, Evan Kransdorf, Adam Cochrane, Alan Glanville, Jennifer Gray. Utilization of hepatitis C virus–infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statementThe Journal of Heart and Lung Transplantation 2020; 39(5): 418 doi: 10.1016/j.healun.2020.03.004
32
Diğdem Özer Etik, Nuretdin Suna, Serkan Öcal, Haldun Selçuk, Ülkü Dağlı, Turan Çolak, Fatih Hilmioğlu, Ahmet Sedat Boyacıoğlu, Mehmet Haberal. Successful Treatment With Direct-Acting Antiviral Agents of Hepatitis C in Patients With End-Stage Renal Disease and Kidney Transplant RecipientsExperimental and Clinical Transplantation 2019; 17(1): 52 doi: 10.6002/ect.2018.0095
33
Deirdre Sawinski, Tiffany Wong, Simin Goral. Current state of kidney transplantation in patients with HIV, hepatitis C, and hepatitis B infectionClinical Transplantation 2020; 34(10) doi: 10.1111/ctr.14048
34
Dimitrios Farmakiotis, Zoe Weiss, Amy L. Brotherton, Paul Morrissey, Reginald Gohh, Kendra Vieira, Lynn E. Taylor, Joseph M. Garland. Successful Kidney Transplantation in a Recipient Coinfected with Hepatitis C Genotype 2 and HIV from a Donor Infected with Hepatitis C Genotype 1 in the Direct-Acting Antiviral EraCase Reports in Hepatology 2020; 2020: 1 doi: 10.1155/2020/7679147
35
Helen Ingrid Opdam, Rohit D'Costa. Critical Care Nephrology2019; : 805 doi: 10.1016/B978-0-323-44942-7.00132-1
36
Wisit Cheungpasitporn, Charat Thongprayoon, Karn Wijarnpreecha, Ankit Sakhuja, Wonngarm Kittanamongkolchai, Jackrapong Bruminhent. Efficacy and safety of direct-acting antivirals for treatment of hepatitis C infected kidney transplant recipients; a meta-analysisJournal of Nephropharmacology 2017; 6(2): 49 doi: 10.15171/npj.2017.04